Dear Supporter,
Welcome to our July 2010 Partnership for Cures eNewsletter.
Thanks to everyone who completed the "eNewsletter Questionnaire."
Your ideas will help us keep you better informed about how you support us to impact
the lives of patients who need help right now!
Check out these stories
-
The government picking up on PFC's Rediscovery Research™!
-
The Longest Day of Golf's great success!
-
The progress of some of our research projects!
Vice President of Advancement
|
For every new follower On...
|

Over the next 30 days on any of these social media sites,
$1.00 will be donated to the PFC Advocate Fund!
Share this
and let's reach 1000 followers in the next 30 days!
|
|
Repurposing News:
It's not just at PFC anymore!
|
FDA Database Aims to Spark Orphan-Disease
Drug Development-Wall Street Journal June 18th, 2010 by Amy Dockser Marcus.
For months now, the Food and Drug Administration has been trying novel ways of encouraging
drug makers to develop drugs for rare diseases. Today the agency's Office of Orphan
Products Development is launching a new gambit-a database of FDA-approved compounds
and products that show promise in rare diseases too. The concept is called
"repurposing" - finding new ways to use products that have already been okayed by
the FDA for some other use. Full Story.
Partnership for Cures and Goldman Philanthropic
Partnerships were pioneers in Rediscovery Research™. Our idea is
catching on with the science industry, and now with the government! Repurposing
drugs is one of the four main Rediscovery Research™ methods we advocate to
quickly, safely and affordably deliver solutions to patients!
|
PFC & The Longest
Days of Golf
|
The
2010 Longest Day of
Golf-Chicago
was a huge success!
18 golfers played from 5:30 am until 9:15 pm on June 21 to raise funds for prostate
cancer research!
Our heartfelt thanks to the golfers
and their friends, their business contacts and their family members who
support this charity event every year.
Special thanks to Board members Steve Goldsher, Kevin Krantz and Peter Kupferberg
who provided the volunteer support to make this a spectacular event.
PFC would also like to extend a special thank you to Larry Snyder at ABC-7 Sports
for donating prizes for the golfers, Ticketmaster for donating an executive suite
for a White Sox game and Cubs tickets, Jaci Krandel at Jaci's Cookies for donating
delicious cookies, and Bryn Mawr Country Club for allowing us to use their beautiful
course.
And don't forget-the
LDOG-Rockford is going to be held at the Silver Ridge golf course on Wednesday
August 11th 2010! To learn
more please contact PFC's Micha Siegel at 312-696-1368 ( msiegel@4cures.org) or check out our website.
|
What's
Happening At PFC
|
 This is the latest quarterly update on the progress in our Longest
Day of Golf prostate cancer research projects. Your support is
already touching patients' live in less than one year...now that's IMPACT!
The goal of Drs. Eggener's and Oto's research is to
test an MRI guided laser that can destroy prostate cancer cells without harming
surrounding tissue. Five patients have been treated so far
with no complications and good results! The patients ranged in age from the
50's to mid 70's....all very active and physiologically younger than their chronologic
age. The treatment takes about two hours. All
patients walked out of the hospital the same day. Thus far, no side effects.
Patients returned to normal activities the following day. All treatments are
considered a success, and 6 month follow-ups are scheduled for each patient.
For more information, click here.
The goal of Dr. Szmulewitz's research is to find markers
on prostate cancer cells in the blood of patients to test new drugs and determine
how well those drugs work. Dr. Szmulewitz began to use chemicals
that stick to different markers on the prostate cancer cells. This allowed
him to know which markers are important and how easily the prostate cancer cells
can be found in the blood. This is the first time that a researcher has been
able to evaluate more than one marker on the surface of a prostate cancer cell at
the same time. This should lead to individualized prostate cancer treatment
for patients that don't respond to traditional treatment. For more information, click here.
|
Our Mission
Partnership for Cures raises funds for Rediscovery Research™
that reuses, recombines and reapplies existing science and medicine to quickly,
safely and affordably create new treatments for patients with catastrophic diseases
who need help NOW!
|
|
|
|
|
|
Donate Now
|
|
Become a philanthropic investor and help us fund innovative and inexpensive medical
research with a gift of
$25, $50, $100.
|
Together we can help create fast, safe and effective treatments
for those suffering from disease while they are still able to benefit!
Don't forget to check with your employer about matching charitable giving.
All gifts are tax deductible
to the full extent of the law.
Click here to
|
|
Board & Staff
|
Executive
Board
John Aalbregtse
Chair
JA and Associates, LLC
Margaret Christie
Secretary
Golan and Christie, LLC
Steve Goldsher
Treasurer
Graphic Purchasing Solutions, LLC
Leslie Anderson
Senior VP-District Market Manager
Harris Bank
Steve Braun, CLU Northwestern Mutual Financial Network
Liz Downey
Liz Downey and Associates
Thomas Furst
Furst Search Group
Mark Kosiek
The PrivateBank and Trust
Kevin R. Krantz
Stahl, Cowen, Crowley, LLC
Robert Miller
Millco Investments
Jerry Paris
MW Automotive Enterprises, Inc
Dr. Susan Sherman
Mont Clare Animal Hospital
Special
Advisors
Dr. Stephen Kron, Chair
Science Advisory Board University of Chicago
Laura Goff, Chair
Finance Committee
Deloitte Tax LLP
Neil Hirsch, Chair Development Committee
Judy Hirsch Foundation
Peter Kupferberg
Co-Chair, Development Committee
Gofen and Glossberg
Michael L. Lucas, Chair
Corporate Foundation Advancement
Leading Edge Investment Advisors
Dr. Alana Baum, Chair
Jasper Against Batten Fund
Lisa Kelly, Chair
Dogs for Cures Foundation
Scott Rothrock, Chair
Cure for MS Fund
Founders
George Goldman
Asset Partners
Judith A. Goldman
Goldman Philanthropic Partnerships
Senior Staff
Dr. Bruce Bloom
President and Chief Science Officer
Micha Siegel
VP of Advancement
|
|
|
|